Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

…, V Nand Yadav, R Ravindran, AK Bruzek… - Neuro …, 2022 - academic.oup.com
Background Diffuse Midline Glioma (DMG) with the H3K27M mutation is a lethal childhood
brain cancer, with patients rarely surviving 2 years from diagnosis. Methods We conducted a …

Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response

MM Reinholz, AK Bruzek, DW Visscher… - The lancet …, 2009 - thelancet.com
Abnormalities of chromosome 17, recognised over two decades ago to be important in
tumorigenesis, often occur in breast cancer. Changes of specific loci on chromosome 17 …

Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations

…, S Chi, SH Ramkissoon, B Mullan, AK Bruzek… - Neuro …, 2019 - academic.oup.com
As the field of neuro-oncology makes headway in uncovering the key oncogenic drivers in
pediatric glioma, the role of precision diagnostics and therapies continues to rapidly evolve …

[HTML][HTML] Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma

…, A Paul, AK Bruzek, K Wierzbicki… - The Journal of …, 2020 - Am Soc Clin Investig
Pediatric and adult high-grade gliomas (HGGs) frequently harbor PDGFRA alterations. We
hypothesized that cotreatment with everolimus may improve the efficacy of dasatinib in …

Electronic DNA analysis of CSF cell-free tumor DNA to quantify multi-gene molecular response in pediatric high-grade glioma

AK Bruzek, K Ravi, A Muruganand, J Wadden… - Clinical Cancer …, 2020 - AACR
Purpose: Pediatric high-grade glioma (pHGG) diagnosis portends poor prognosis and
therapeutic monitoring remains difficult. Tumors release cell-free tumor DNA (cf-tDNA) into …

[HTML][HTML] Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing

…, BS Newell, J Bugbee, V John, AK Bruzek… - Communications …, 2022 - nature.com
Molecular markers are essential for cancer diagnosis, clinical trial enrollment, and some
surgical decision making, motivating ultra-rapid, intraoperative variant detection. Sequencing-…

A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites

…, GG Reinholz, LA Jonart, KA Kitzmann, AK Bruzek… - Bone, 2010 - Elsevier
Despite palliative treatments, tumor-induced bone disease (TIBD) remains highly debilitating
for many cancer patients and progression typically results in death within two years. …

The preventable shunt revision rate: a multicenter evaluation

…, KM Huntoon, CO Maher, AK Bruzek… - …, 2019 - journals.lww.com
METHODS Nine participating centers in North America provided at least 2 years of consecutive
shunt operations. Index surgery was defined as new shunt implantation, or revision of an …

[HTML][HTML] Control of centrin stability by Aurora A

…, TM Greenwood, VC Negron, AK Bruzek… - PloS one, 2011 - journals.plos.org
Aurora A is an oncogenic serine/threonine kinase which can cause cell transformation and
centrosome amplification when over-expressed. Human breast tumors show excess Aurora A …

Syringomyelia in children with closed spinal dysraphism: long-term outcomes after surgical intervention

AK Bruzek, J Starr, HJL Garton, KM Muraszko… - Journal of …, 2019 - thejns.org
OBJECTIVE The nature of the relationship between spinal cord syrinx and tethered cord is
not well known. It is unclear if surgical cord untethering results in resolution or improvement of …